These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 26406331)
1. Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients. Nielsen MJ; Kazankov K; Leeming DJ; Karsdal MA; Krag A; Barrera F; McLeod D; George J; Grønbæk H PLoS One; 2015; 10(9):e0137302. PubMed ID: 26406331 [TBL] [Abstract][Full Text] [Related]
2. Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury. Nielsen MJ; Karsdal MA; Kazankov K; Grønbaek H; Krag A; Leeming DJ; Schuppan D; George J Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1242-1252. PubMed ID: 27696451 [TBL] [Abstract][Full Text] [Related]
3. Assessment of liver fibrosis progression and regression by a serological collagen turnover profile. Karsdal MA; Hjuler ST; Luo Y; Rasmussen DGK; Nielsen MJ; Holm Nielsen S; Leeming DJ; Goodman Z; Arch RH; Patel K; Schuppan D Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G25-G31. PubMed ID: 30160980 [TBL] [Abstract][Full Text] [Related]
4. Altered balance between collagen formation and degradation after successful direct-acting antiviral therapy of chronic hepatitis C. Laursen TL; Villesen IF; Leeming DJ; Karsdal MA; Sølund C; Tarp B; Kristensen LH; Holmboe CH; Leutscher P; Laursen AL; Gudmann NS; Grønbaek H J Viral Hepat; 2021 Feb; 28(2):236-244. PubMed ID: 33058390 [TBL] [Abstract][Full Text] [Related]
5. Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome. Huang Y; de Boer WB; Adams LA; MacQuillan G; Bulsara MK; Jeffrey GP J Hepatol; 2014 Jul; 61(1):22-7. PubMed ID: 24607623 [TBL] [Abstract][Full Text] [Related]
6. Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C. Nielsen MJ; Veidal SS; Karsdal MA; Ørsnes-Leeming DJ; Vainer B; Gardner SD; Hamatake R; Goodman ZD; Schuppan D; Patel K Liver Int; 2015 Feb; 35(2):429-37. PubMed ID: 25308921 [TBL] [Abstract][Full Text] [Related]
7. Protein fingerprinting of the extracellular matrix remodelling in a rat model of liver fibrosis--a serological evaluation. Leeming DJ; Byrjalsen I; Jiménez W; Christiansen C; Karsdal MA Liver Int; 2013 Mar; 33(3):439-47. PubMed ID: 23279004 [TBL] [Abstract][Full Text] [Related]
8. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis. Dobrota R; Jordan S; Juhl P; Del Papa N; Maurer B; Becker M; Mihai C; Bay-Jensen AC; Karsdal MA; Siebuhr AS; Distler O RMD Open; 2024 May; 10(2):. PubMed ID: 38806188 [TBL] [Abstract][Full Text] [Related]
9. Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients. Shaker OG; Senousy MA J Viral Hepat; 2017 Aug; 24(8):636-644. PubMed ID: 28211229 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C. Cheung KJ; Tilleman K; Deforce D; Colle I; Moreno C; Gustot T; Van Vlierberghe H Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):701-10. PubMed ID: 21623191 [TBL] [Abstract][Full Text] [Related]
11. Serum biomarkers of collagen turnover as potential diagnostic tools in diffuse systemic sclerosis: A cross-sectional study. Juhl P; Bay-Jensen AC; Karsdal M; Siebuhr AS; Franchimont N; Chavez J PLoS One; 2018; 13(12):e0207324. PubMed ID: 30507931 [TBL] [Abstract][Full Text] [Related]
13. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis. Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349 [TBL] [Abstract][Full Text] [Related]
14. Accelerated collagen turnover in women with angina pectoris without obstructive coronary artery disease: An iPOWER substudy. Nielsen SH; Mygind ND; Michelsen MM; Bechsgaard DF; Suhrs HE; Genovese F; Nielsen HB; Brix S; Karsdal M; Prescott E; Kastrup J Eur J Prev Cardiol; 2018 May; 25(7):719-727. PubMed ID: 29436257 [TBL] [Abstract][Full Text] [Related]
15. CT texture analysis of the liver for assessing hepatic fibrosis in patients with hepatitis C virus. Lubner MG; Jones D; Kloke J; Said A; Pickhardt PJ Br J Radiol; 2019 Jan; 92(1093):20180153. PubMed ID: 30182750 [TBL] [Abstract][Full Text] [Related]
16. Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer. Christensen TD; Jensen C; Larsen O; Leerhøy B; Hansen CP; Madsen K; Høgdall D; Karsdal MA; Chen IM; Nielsen D; Johansen JS; Willumsen N Int J Cancer; 2023 Mar; 152(5):1036-1049. PubMed ID: 36455598 [TBL] [Abstract][Full Text] [Related]
17. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis. Attallah AM; Albannan MS; Omran MM; Zayed R; Saif S; Farid A; Hassany M; Yosry A; Omran D Br J Biomed Sci; 2019 Jul; 76(3):105-110. PubMed ID: 30924403 [No Abstract] [Full Text] [Related]
18. Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension. Leeming DJ; Karsdal MA; Byrjalsen I; Bendtsen F; Trebicka J; Nielsen MJ; Christiansen C; Møller S; Krag A Aliment Pharmacol Ther; 2013 Nov; 38(9):1086-96. PubMed ID: 24099470 [TBL] [Abstract][Full Text] [Related]
19. Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART. Dold L; Nielsen MJ; Praktiknjo M; Schwarze-Zander C; Boesecke C; Schierwagen R; Mohr R; Wasmuth JC; Jansen C; Bischoff J; Rockstroh JK; Karsdal MA; Spengler U; Trebicka J; Leeming DJ PLoS One; 2019; 14(7):e0219526. PubMed ID: 31295293 [TBL] [Abstract][Full Text] [Related]
20. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Ferraioli G; Tinelli C; Dal Bello B; Zicchetti M; Filice G; Filice C; Hepatology; 2012 Dec; 56(6):2125-33. PubMed ID: 22767302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]